Evidence map›Paper›PMID 33495216›Full record

ArticleAntimicrobial agents and chemotherapy2021

Reply to Béranger et al., "Integration of Continuous Renal Replacement Therapy in a Meropenem Population Pharmacokinetics Model in Critically Ill Children".

Jumpei Saito, Kensuke Shoji, Yusuke Oho, Hiroki Kato, Shotaro Matsumoto, Satoshi Aoki, Hidefumi Nakamura, Takanori Ogawa, Mayumi Hasegawa, Akimasa Yamatani and 1 more

Open access · greenAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Jumpei Saito *Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan saito-jn@ncchd.go.jp.ORCID 0000-0003-4799-5562
Kensuke Shoji *Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
Yusuke OhoDepartment of Pharmacy, National Center for Child Health and Development, Tokyo, Japan.
Hiroki KatoDivision of Critical Care Medicine, Department of Critical Care and Anesthesia, National Center for Child Health and Development, Tokyo, Japan.
Shotaro MatsumotoDivision of Critical Care Medicine, Department of Critical Care and Anesthesia, National Center for Child Health and Development, Tokyo, Japan.
Satoshi AokiDivision of Critical Care Medicine, Department of Critical Care and Anesthesia, National Center for Child Health and Development, Tokyo, Japan.
Hidefumi NakamuraDepartment of Research and Development Supervision, National Center for Child Health and Development, Tokyo, Japan.
Takanori OgawaCertara G. K., Tokyo, Japan.
Mayumi HasegawaCertara G. K., Tokyo, Japan.
Akimasa YamataniDepartment of Pharmacy, National Center for Child Health and Development, Tokyo, Japan.
Isao MiyairiDivision of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
National Center For Child Health and Development · JPUniversity of Tennessee Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Continuous Renal Replacement TherapyCritical IllnessAnti-Bacterial AgentsChildHumansMeropenemThienamycinsAnti-Bacterial AgentsMeropenemThienamycins

Identifiers

PMID33495216
PMCPMC8097448
OpenAlexW3123423560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.